BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
AstraZeneca
Fuji
Novartis
Deloitte
Daiichi Sankyo
Baxter
McKesson
Merck

Generated: January 22, 2018

DrugPatentWatch Database Preview

Methotrexate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methotrexate sodium and what is the scope of methotrexate sodium freedom to operate?

Methotrexate sodium
is the generic ingredient in twelve branded drugs marketed by Abic, Pharmacia And Upjohn, Hospira, Fresenius Kabi Usa, Abraxis Pharm, Norbrook, Pharmachemie Usa, West-ward Pharms Int, Accord Hlthcare, Mylan Labs Ltd, Pharmachemie Bv, Sandoz Inc, Bristol, Bristol Myers, Bristol Myers Squibb, Silvergate Pharms, Barr, Dava Pharms Inc, Duramed Pharms Barr, Mylan, Sun Pharma Global, and Zydus Pharms Usa Inc, and is included in forty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Methotrexate sodium has two patent family members in two countries.

There are twenty drug master file entries for methotrexate sodium. Twenty-eight suppliers are listed for this compound.
Pharmacology for methotrexate sodium

US Patents and Regulatory Information for methotrexate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb MEXATE-AQ PRESERVED methotrexate sodium INJECTABLE;INJECTION 089887-001 Apr 14, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol MEXATE methotrexate sodium INJECTABLE;INJECTION 086358-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira METHOTREXATE SODIUM methotrexate sodium INJECTABLE;INJECTION 011719-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int METHOTREXATE SODIUM methotrexate sodium INJECTABLE;INJECTION 089342-001 Sep 16, 1986 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Norbrook METHOTREXATE SODIUM methotrexate sodium INJECTABLE;INJECTION 088648-001 May 9, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare METHOTREXATE SODIUM PRESERVATIVE FREE methotrexate sodium INJECTABLE;INJECTION 040716-001 Apr 30, 2007 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol MEXATE methotrexate sodium INJECTABLE;INJECTION 086358-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr TREXALL methotrexate sodium TABLET;ORAL 040385-003 Mar 21, 2001 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr TREXALL methotrexate sodium TABLET;ORAL 040385-002 Mar 21, 2001 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm METHOTREXATE SODIUM methotrexate sodium INJECTABLE;INJECTION 089322-001 Jun 13, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
Baxter
Cerilliant
Covington
Federal Trade Commission
AstraZeneca
Farmers Insurance
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot